Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam for Intraoperative Sedation in Pediatric and Adolescent Patients
NCT07036419Phase 3Completed
- Sponsor
- Hengrui
- Start
- Jul 2025
- Primary completion
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of remimazolam, sponsored by Hengrui. Started Jul 2025; status: completed.
02
Drugs
remimazolam
Beyond the preview
Go deeper on NCT07036419.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07036419.